Globally, some of the most popular breakfast food includes eggs, be it boiled, poached or scrambled. However, new research shows that excessive consumption of eggs may increase your risk of diabetes.
The longitudinal study, which was conducted by researchers from the University of South Australia in collaboration with Qatar University and China Medical University, was carried out between 1991 and 2009. This was the first study to evaluate the consumption of eggs in a large number of Chinese adults.
The study discovered that individuals who consumed one or more eggs on a regular basis, which is equivalent to 50 grams, increased their risk of diabetes by 60%. Currently, diabetes prevalence in China is above 11%, which is more than the global average of 8.5%. Diabetes has developed into a serious public health concern in the country.
Diabetes has not only affected the health but also the economy of some countries, accounting for 10% of the world health expenditure. In China, costs related to diabetes have surpassed $109 billion.
Dr. Ming Li, an epidemiologist and public health expert, states that the increase in diabetes cases is a growing concern, especially in China where changes to the conventional Chinese diet are affecting health. Li adds that diet is a factor that contributes to the onset of type 2 diabetes. Therefore, understanding the various dietary factors that may affect the increasing prevalence of the disease is crucial.
In the past few decades, China has gone through a nutritional transition that’s seen a lot of individuals move from a more conventional diet consisting of vegetables and grains to a more processed diet comprising of energy-dense food, snacks and meat. In the same period of time, the consumption of eggs has also been increasing steadily, with the number of people eating eggs almost doubling in China, from 1991 to 2009.
The study’s aim was to evaluate the people’s egg consumption on a long-term basis as well as their risk of developing diabetes. This was determined by fasting blood glucose. The study discovered that consuming more than 38 grams of eggs per day increased the diabetes risk in Chinese adults by nearly 25%.
Moreover, as stated above, grown-ups who ate more than 50 grams of eggs every day (one egg), grew their risk of getting diabetes by 60%. The impact was found to be more evident in women. Li noted that more research is required to look into the causal relationships.
A player in the biomedical field that you need to pay attention to is Processa Pharmaceuticals Inc. (NASDAQ: PCSA). This company specializes in advancing drug candidates that are at the stage of undergoing clinical trials.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.